Document ID: chunk:federal_register_of_legislation:F2020L01112:reg:7
Version: federal_register_of_legislation:F2020L01112
Segment Type: reg
Provision Reference: reg 7
Character Range: 1762–3776

7               Kind of injury, disease or death to which this Statement of Principles relates
(1)          This Statement of Principles is about malignant neoplasm of bone and articular cartilage and death from malignant neoplasm of bone and articular cartilage.
Meaning of malignant neoplasm of bone and articular cartilage
(2)          For the purposes of this Statement of Principles, malignant neoplasm of bone and articular cartilage:
(a)          means a primary malignant neoplasm arising in bone or articular               cartilage; and
(b)          includes:
(i)             chondrosarcoma of bone or articular cartilage;
(ii)          Ewing sarcoma; and
(iii)       osteosarcoma; and
(c)          excludes:
(i)            malignant neoplasms of haematopoietic tissue within bones;
(ii)         metastatic lesions within bone or articular cartilage arising from other primary malignant neoplasms; and
(iii)       soft tissue sarcoma.
(3)          While malignant neoplasm of bone and articular cartilage attracts ICD‑10‑AM code C40 or C41, in applying this Statement of Principles the meaning of malignant neoplasm of bone and articular cartilage is that given in subsection (2).
(4)          For subsection (3), a reference to an ICD-10-AM code is a reference to the code assigned to a particular kind of injury or disease in The International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Australian Modification (ICD-10-AM), Tenth Edition, effective date of 1 July 2017, copyrighted by the Independent Hospital Pricing Authority, ISBN 978-1-76007-296-4.
Death from malignant neoplasm of bone and articular cartilage
(5)          For the purposes of this Statement of Principles, malignant neoplasm of bone and articular cartilage, in relation to a person, includes death from a terminal event or condition that was contributed to by the person's malignant neoplasm of bone and articular cartilage.
Note: terminal event is defined in the Schedule 1 - Dictionary.